Blood Test Identifies Gene Deformity Known As Lynch Syndrome

MANSFIELD, OH - A network of 50 hospitals, including OhioHealth MedCentral Mansfield, are joining forces across the Buckeye State, using a blood test to identify those most at risk for a gene deformity known as Lynch Syndrome and to help them avoid a diagnosis of cancer.

Lynch Syndrome is a condition that prevents your body from properly repairing damaged D-N-A.

When that happens, your risk of getting cancer at some point in your life is very high.

The good news is, a simple blood test can tell you if you have Lynch Syndrome.

And 50 hospitals across Ohio have joined forces to test for it.

In many cases, the tests are free of charge.

Experts at The Ohio State University Comprehensive Cancer Center say if you or a close relative has been diagnosed with colorectal cancer since 2013, you should consider a test for Lynch Syndrome.

Read More: http://www.wmfd.com/news/single.asp?story=70230

Comments

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome

Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer

Key Points Question What is the frequency and spectrum of cancer susceptibility gene mutations among patients with colorectal cancer diagnosed at younger than 50 years? Findings In this cohort study of 450 patients with early-onset colorectal cancer, 72 (16%) had a pathogenic mutation. Panel testing identified mutations in patients that may have otherwise been missed; specifically, 24 of 72 patients (33.3%) who were mutation positive did not meet testing criteria for the gene(s) in which they had a mutation. Meaning Multigene panel testing should be considered for all patients with early-onset colorectal cancer. Read More: Prevalence and Spectrum of Gene Mutations and Colorectal Cancer

HNPCC Info

Search This Blog